查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1324079

側流化驗的全球市場

Lateral Flow Assays
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 461 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

側流化驗的全球市場在2030年前將達到141億美元

在COVID-19後改變的商務環境中，2022年估算為94億美元的側流化驗的全球市場在2030年前將達到之前達到141億美元，在2022年～2030年間將以年複合成長率5.2％增長。本報告所分析的市場區隔之一的套件&試劑將記錄年複合成長率5.3％，到分析期間結束時將達到118億美元。考慮疫情後的復甦，Lateral Flow Readers領域今後8年的年複合成長率將修正為4.3％。

美國市場估算為36億美元，中國則將以年複合成長率7.5％增長

美國的側流化驗市場在2022年估算為36億美元。作為世界第2大經濟大國的中國，在2022年～2030年的分析期間中將以年複合成長率7.5％推移，2030年之前市場規模達到12億美元。其他熱門的地區市場有日本和加拿大，在2022年～2030年間將各以3.2％和4.9％的速度成長。在歐洲市場中，德國預計將以年複合成長率約4.1％成長。

調查對象企業範例

  • Merck KGaA
  • Hologic, Inc.
  • Danaher Corporation
  • Polysciences, Inc.
  • Iul, S.A.
  • ANP Technologies, Inc.
  • Bioporto Diagnostics A/S
  • Abingdon Health Ltd.
  • BBI Solutions
  • IMMY
  • Creative Diagnostics
  • Pribolab Pte., Ltd.
  • DCN Diagnostics
  • Microcoat Biotechnologie GmbH
  • DIALUNOX GmbH

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 全球市場概要
  • 最近的市場活動
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 非洲

第4章 競爭

簡介目錄
Product Code: MCP12971

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Lateral Flow Assays Market to Reach $14.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Lateral Flow Assays estimated at US$9.4 Billion in the year 2022, is projected to reach a revised size of US$14.1 Billion by 2030, growing at aCAGR of 5.2% over the period 2022-2030. Kits & Reagents, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$11.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lateral Flow Readers segment is readjusted to a revised 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 7.5% CAGR

The Lateral Flow Assays market in the U.S. is estimated at US$3.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 4.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Select Competitors (Total 55 Featured) -

  • Merck KGaA
  • Hologic, Inc.
  • Danaher Corporation
  • Polysciences, Inc.
  • Iul, S.A.
  • ANP Technologies, Inc.
  • Bioporto Diagnostics A/S
  • Abingdon Health Ltd.
  • BBI Solutions
  • IMMY
  • Creative Diagnostics
  • Pribolab Pte., Ltd.
  • DCN Diagnostics
  • Microcoat Biotechnologie GmbH
  • DIALUNOX GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of Covid-19 and a Looming Global Recession
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Challenges and Opportunities for Clinical Diagnostics amid the Pandemic
    • Impact of COVID-19 on Lateral Flow Assays Market
    • Performance Analysis of COVID-19 Tests
    • COVID-19 Cases Worldwide by Country: As on May 17, 2021
    • Lateral Flow Assay-based Tests Soar into Spotlight during COVID-19 Pandemic
    • LFAS Arms Nations to Battle the Coronavirus
    • Lateral Flow Assays - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • GLOBAL MARKET OVERVIEW
    • A Prelude to Lateral Flow Technology
    • Lateral Flow Assays: An Introduction
    • Lateral Flow Assays: A Mighty, Paper-based Diagnostics Approach
    • Lateral Flow Assays Market Appears Poised to Experience Uninterrupted Flow Ahead
    • Clinical Testing Remains Primary Application Segment of Lateral Flow Assays Market
    • Rising Incidence of Infectious Conditions Ignite Demand
    • LFA Overcomes Testing Barriers
    • Emerging Applications Present Lucrative Opportunities
    • The US Retains Leadership Tag in Global Lateral Flow Assays Market
    • Competitive Scenario
    • Market Outlook
  • RECENT MARKET ACTIVITY
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Infectious Diseases to Drive LFA Market
    • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • Global Malaria Case Incidence Rate (per 1,000 population) for the Years 2015, 2016, 2017 & 2018
    • Global TB Cases (In Millions) Reported to Have Been Treated for the Years 2015-2019
    • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
    • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018
    • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
    • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
    • Home HIV Testing Emerges as a Lucrative Option
    • Viral Hepatitis Testing Presents Opportunities for Lateral Flow Assays Market
    • Hepatitis B prevalence Worldwide by Region
    • Uptrend in Healthcare Spending Creates Fertile Environment
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Ageing Demographics to Drive Demand
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Self-Diagnosis Emerge as Notable Trend
    • New Approvals of Self-Test Devices to Give a Boost to the Market
    • Lateral Flow Assays Hold Rosy Outlook with Emerging Applications Areas
    • LFAs Gains Foothold in Multiplexing
    • Multiplexed Point-Of-Care Testing
    • Remote Healthcare Benefits Lateral Flow Assays Market
    • Lateral Flow Assays to Become Landmark Approach in Precision Diagnostics
    • Lateral Flow Assays & Precision Diagnostics
    • Digitalization of Lateral Flows to Support Healthcare
    • Digitalized Lateral Flow Assays: An Exciting Platform to Change Data-Driven Healthcare Domain
    • Lateral Flow Assays Emerge as Integral Components of Food Safety & Environmental Testing
    • Novel Lateral Flow Assay Marks Shift from Reactive to Proactive Food Safety Testing Approach
    • Technological Advancements Remain Crucial to Future Growth
    • Researchers Develop Novel Technique to Significantly Increase Accuracy of Lateral Flow Tests
    • Smartphone-based Fully-Quantitative Lateral Flow Assay Analyzer for Reliable & Quick Diagnosis
    • Innovative Lateral Flow Immunoassays Find Increasing Role in Detection of Dengue & Zika Virus
    • Abingdon Health Introduced ADxLR5® Developer for Assay Development
    • Rapid Tests Connectivity with Wireless Data Platforms
    • Miniaturization of Analytical Instruments Presents Lucrative Opportunities for Handheld Lateral Flow Assay Readers
    • Low Accuracy Remains a Major Restraint
    • Limited Reimbursement & Raw Material Supply Issues as Key Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Lateral Flow Readers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Lateral Flow Readers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Lateral Flow Readers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Clinical Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Clinical Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Veterinary Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Veterinary Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Veterinary Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 31: World Lateral Flow Assays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Lateral Flow Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Lateral Flow Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • INDIA
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: India 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: India 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: India 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Lateral Flow Assays by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Revenues for Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 203: Brazil Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Brazil Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 205: Brazil 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 212: Mexico Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Mexico Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 214: Mexico 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 221: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Rest of Latin America Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 223: Rest of Latin America 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 230: Middle East Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Middle East Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 232: Middle East 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
  • AFRICA
    • Lateral Flow Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 239: Africa Recent Past, Current & Future Analysis for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Africa Historic Review for Lateral Flow Assays by Product - Kits & Reagents and Lateral Flow Readers Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 241: Africa 16-Year Perspective for Lateral Flow Assays by Product - Percentage Breakdown of Value Revenues for Kits & Reagents and Lateral Flow Readers for the Years 2014, 2023 & 2030
    • TABLE 242: Africa Recent Past, Current & Future Analysis for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Africa Historic Review for Lateral Flow Assays by Application - Clinical Testing, Veterinary Diagnostics and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 244: Africa 16-Year Perspective for Lateral Flow Assays by Application - Percentage Breakdown of Value Revenues for Clinical Testing, Veterinary Diagnostics and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 245: Africa Recent Past, Current & Future Analysis for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Africa Historic Review for Lateral Flow Assays by End-Use - Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 247: Africa 16-Year Perspective for Lateral Flow Assays by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION